Skip to main content
PMC home page
Canadian Family Physician logoLink to Canadian Family Physician
. 2000 Sep;46:1806–1813.

Treating obesity. Lost cause or new opportunity?

G Plourde 1
PMCID: PMC2145045  PMID: 11013799

Abstract

OBJECTIVE: To review therapies for treating obese patients. QUALITY OF EVIDENCE: Advice in this paper is based mainly on the results of randomized controlled trials. Some data from smaller, more physiologic studies are included. When appropriate, advice is based on consensus. MAIN MESSAGE: Recent medical evidence indicates that a modest weight loss (5% to 10%) can alleviate symptoms of obesity-related comorbidity. Treatment of obesity should be comprehensive and integrated into a multi-component approach and should involve both patients and their families. The main challenge of obesity is maintaining a reduced weight. CONCLUSION: A multi-component approach to treating obesity can help make treatment less frustrating and more rewarding for patients and physicians.

Full text

PDF
1807

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abenhaim L., Moride Y., Brenot F., Rich S., Benichou J., Kurz X., Higenbottam T., Oakley C., Wouters E., Aubier M. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996 Aug 29;335(9):609–616. doi: 10.1056/NEJM199608293350901. [DOI] [PubMed] [Google Scholar]
  2. Andersen R. E., Wadden T. A., Bartlett S. J., Vogt R. A., Weinstock R. S. Relation of weight loss to changes in serum lipids and lipoproteins in obese women. Am J Clin Nutr. 1995 Aug;62(2):350–357. doi: 10.1093/ajcn/62.2.350. [DOI] [PubMed] [Google Scholar]
  3. Bandini L. G., Schoeller D. A., Cyr H. N., Dietz W. H. Validity of reported energy intake in obese and nonobese adolescents. Am J Clin Nutr. 1990 Sep;52(3):421–425. doi: 10.1093/ajcn/52.3.421. [DOI] [PubMed] [Google Scholar]
  4. Birmingham C. L., Muller J. L., Palepu A., Spinelli J. J., Anis A. H. The cost of obesity in Canada. CMAJ. 1999 Feb 23;160(4):483–488. [PMC free article] [PubMed] [Google Scholar]
  5. Björntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 1990 Jul-Aug;10(4):493–496. [PubMed] [Google Scholar]
  6. Björntorp P. Classification of obese patients and complications related to the distribution of surplus fat. Nutrition. 1990 Mar-Apr;6(2):131–137. [PubMed] [Google Scholar]
  7. Björvell H., Rössner S. A ten-year follow-up of weight change in severely obese subjects treated in a combined behavioural modification programme. Int J Obes Relat Metab Disord. 1992 Aug;16(8):623–625. [PubMed] [Google Scholar]
  8. Blackburn G. Effect of degree of weight loss on health benefits. Obes Res. 1995 Sep;3 (Suppl 2):211s–216s. doi: 10.1002/j.1550-8528.1995.tb00466.x. [DOI] [PubMed] [Google Scholar]
  9. Blair S. N. Evidence for success of exercise in weight loss and control. Ann Intern Med. 1993 Oct 1;119(7 Pt 2):702–706. doi: 10.7326/0003-4819-119-7_part_2-199310011-00015. [DOI] [PubMed] [Google Scholar]
  10. Bouchard C., Tremblay A., Després J. P., Nadeau A., Lupien P. J., Thériault G., Dussault J., Moorjani S., Pinault S., Fournier G. The response to long-term overfeeding in identical twins. N Engl J Med. 1990 May 24;322(21):1477–1482. doi: 10.1056/NEJM199005243222101. [DOI] [PubMed] [Google Scholar]
  11. Bouchard C., Tremblay A., Nadeau A., Dussault J., Després J. P., Theriault G., Lupien P. J., Serresse O., Boulay M. R., Fournier G. Long-term exercise training with constant energy intake. 1: Effect on body composition and selected metabolic variables. Int J Obes. 1990 Jan;14(1):57–73. [PubMed] [Google Scholar]
  12. Cerulli J., Lomaestro B. M., Malone M. Update on the pharmacotherapy of obesity. Ann Pharmacother. 1998 Jan;32(1):88–102. doi: 10.1345/aph.17039. [DOI] [PubMed] [Google Scholar]
  13. Davidson M. H., Hauptman J., DiGirolamo M., Foreyt J. P., Halsted C. H., Heber D., Heimburger D. C., Lucas C. P., Robbins D. C., Chung J. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999 Jan 20;281(3):235–242. doi: 10.1001/jama.281.3.235. [DOI] [PubMed] [Google Scholar]
  14. Elks M. L. Appetite suppressants as adjuncts in the treatment of obesity. J Fam Pract. 1996 Mar;42(3):287–292. [PubMed] [Google Scholar]
  15. Foreyt J. P., Goodrick G. K. Evidence for success of behavior modification in weight loss and control. Ann Intern Med. 1993 Oct 1;119(7 Pt 2):698–701. doi: 10.7326/0003-4819-119-7_part_2-199310011-00014. [DOI] [PubMed] [Google Scholar]
  16. Glenny A. M., O'Meara S., Melville A., Sheldon T. A., Wilson C. The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord. 1997 Sep;21(9):715–737. doi: 10.1038/sj.ijo.0800495. [DOI] [PubMed] [Google Scholar]
  17. Goldstein D. J. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992 Jun;16(6):397–415. [PubMed] [Google Scholar]
  18. Guy-Grand B. INDEX (international dexfenfluramine study) as a model for long-term pharmacotherapy of obesity in the 1990s. Int J Obes Relat Metab Disord. 1992 Dec;16 (Suppl 3):S5–14. [PubMed] [Google Scholar]
  19. Heal D. J., Aspley S., Prow M. R., Jackson H. C., Martin K. F., Cheetham S. C. Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int J Obes Relat Metab Disord. 1998 Aug;22 (Suppl 1):S18–S29. [PubMed] [Google Scholar]
  20. Heymsfield S. B., Segal K. R., Hauptman J., Lucas C. P., Boldrin M. N., Rissanen A., Wilding J. P., Sjöström L. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med. 2000 May 8;160(9):1321–1326. doi: 10.1001/archinte.160.9.1321. [DOI] [PubMed] [Google Scholar]
  21. Hollander P. A., Elbein S. C., Hirsch I. B., Kelley D., McGill J., Taylor T., Weiss S. R., Crockett S. E., Kaplan R. A., Comstock J. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care. 1998 Aug;21(8):1288–1294. doi: 10.2337/diacare.21.8.1288. [DOI] [PubMed] [Google Scholar]
  22. Kuczmarski R. J., Flegal K. M., Campbell S. M., Johnson C. L. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994 Jul 20;272(3):205–211. doi: 10.1001/jama.272.3.205. [DOI] [PubMed] [Google Scholar]
  23. Lean M. E., Powrie J. K., Anderson A. S., Garthwaite P. H. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med. 1990 Mar-Apr;7(3):228–233. doi: 10.1111/j.1464-5491.1990.tb01375.x. [DOI] [PubMed] [Google Scholar]
  24. Leibel R. L., Rosenbaum M., Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995 Mar 9;332(10):621–628. doi: 10.1056/NEJM199503093321001. [DOI] [PubMed] [Google Scholar]
  25. Lichtman S. W., Pisarska K., Berman E. R., Pestone M., Dowling H., Offenbacher E., Weisel H., Heshka S., Matthews D. E., Heymsfield S. B. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med. 1992 Dec 31;327(27):1893–1898. doi: 10.1056/NEJM199212313272701. [DOI] [PubMed] [Google Scholar]
  26. Macdonald S. M., Reeder B. A., Chen Y., Després J. P. Obesity in Canada: a descriptive analysis. Canadian Heart Health Surveys Research Group. CMAJ. 1997 Jul 1;157 (Suppl 1):S3–S9. [PubMed] [Google Scholar]
  27. Manson J. E., Faich G. A. Pharmacotherapy for obesity -- do the benefits outweigh the risks? N Engl J Med. 1996 Aug 29;335(9):659–660. doi: 10.1056/NEJM199608293350910. [DOI] [PubMed] [Google Scholar]
  28. Marshall E. M. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997 Dec 11;337(24):1775–1776. [PubMed] [Google Scholar]
  29. McGinnis J. M., Foege W. H. Actual causes of death in the United States. JAMA. 1993 Nov 10;270(18):2207–2212. [PubMed] [Google Scholar]
  30. Pavlou K. N., Krey S., Steffee W. P. Exercise as an adjunct to weight loss and maintenance in moderately obese subjects. Am J Clin Nutr. 1989 May;49(5 Suppl):1115–1123. doi: 10.1093/ajcn/49.5.1115. [DOI] [PubMed] [Google Scholar]
  31. Pi-Sunyer F. X. A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther. 1996 Nov-Dec;18(6):1006–1005. doi: 10.1016/s0149-2918(96)80057-9. [DOI] [PubMed] [Google Scholar]
  32. Prochaska J. O., DiClemente C. C., Norcross J. C. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992 Sep;47(9):1102–1114. doi: 10.1037//0003-066x.47.9.1102. [DOI] [PubMed] [Google Scholar]
  33. Silverstone T. Appetite suppressants. A review. Drugs. 1992 Jun;43(6):820–836. doi: 10.2165/00003495-199243060-00003. [DOI] [PubMed] [Google Scholar]
  34. Sjöström L., Rissanen A., Andersen T., Boldrin M., Golay A., Koppeschaar H. P., Krempf M. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet. 1998 Jul 18;352(9123):167–172. doi: 10.1016/s0140-6736(97)11509-4. [DOI] [PubMed] [Google Scholar]
  35. Stock M. J. Sibutramine: a review of the pharmacology of a novel anti-obesity agent. Int J Obes Relat Metab Disord. 1997 Mar;21 (Suppl 1):S25–S29. [PubMed] [Google Scholar]
  36. Stunkard A. J., Sørensen T. I., Hanis C., Teasdale T. W., Chakraborty R., Schull W. J., Schulsinger F. An adoption study of human obesity. N Engl J Med. 1986 Jan 23;314(4):193–198. doi: 10.1056/NEJM198601233140401. [DOI] [PubMed] [Google Scholar]
  37. Tremblay A., Plourde G., Despres J. P., Bouchard C. Impact of dietary fat content and fat oxidation on energy intake in humans. Am J Clin Nutr. 1989 May;49(5):799–805. doi: 10.1093/ajcn/49.5.799. [DOI] [PubMed] [Google Scholar]
  38. Weintraub M., Sundaresan P. R., Schuster B., Averbuch M., Stein E. C., Byrne L. Long-term weight control study. V (weeks 190 to 210). Follow-up of participants after cessation of medication. Clin Pharmacol Ther. 1992 May;51(5):615–618. doi: 10.1038/clpt.1992.73. [DOI] [PubMed] [Google Scholar]
  39. Williamson D. F., Pamuk E., Thun M., Flanders D., Byers T., Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol. 1995 Jun 15;141(12):1128–1141. doi: 10.1093/oxfordjournals.aje.a117386. [DOI] [PubMed] [Google Scholar]
  40. Wood P. D., Stefanick M. L., Williams P. T., Haskell W. L. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med. 1991 Aug 15;325(7):461–466. doi: 10.1056/NEJM199108153250703. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES